Geneva, June 20 -- International Clinical Trials Registry received information related to the study (ISRCTN10801475) titled 'One study, many treatments: a new way to fight muscle loss in later life' on June 12.
Study Type: Interventional
Study Design:
Single-centre platform trial consisting of multiple parallel-group, individually randomized controlled, open-label, proof-of-concept subtrials (Treatment, Efficacy)
Primary Sponsor: Newcastle upon Tyne Hospitals NHS Foundation Trust
Condition:
Sarcopenia
Musculoskeletal Diseases
Intervention:
The platform trial will be made up of a number of randomised controlled subtrials which will run in parallel with each other. It will start with a single subtrial but then others will be added ...